Resection versus transplantation for hepatocellular carcinoma.
Hepatocellular carcinoma is responsible for more than 1 million deaths per year worldwide and thus remains a challenging medical problem. It causes few or no symptoms and the tumour frequently reaches an enormous size by the time of diagnosis in countries where screening is seldom used. It is generally resistant to commercially available anti-neoplastic agents and radiation therapy. The principal treatment continues to be resection, either partial or complete, with liver transplantation. However, less than one-third of patients are surgical candidates for either resection or transplantation at the time of clinical presentation. This review will address the results observed following resection or transplantation for hepatocellular carcinoma.
Esquivel
C O
CO
Department of Surgery, Stanford University School of Medicine, California, USA. esquivel@stanford.edu
Keeffe
E B
EB
Garcia
G
G
Imperial
J C
JC
Millan
M T
MT
Monge
H
H
So
S K
SK
D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation